Back to Search Start Over

Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion

Authors :
Claus Z Simonsen
Ángel Chamorro
Salvador Pedraza
Vincent Thijs
Götz Thomalla
Martin Ebinger
Keith W. Muir
Florent Boutitie
Armin Schneider
Anke Wouters
Bastian Cheng
Lauranne Scheldeman
Erich Bernd Ringelstein
Matthias Endres
Jochen B. Fiebach
Christian Gerloff
Soren Christensen
Rico Laage
Norbert Nighoghossian
Patrick Dupont
Martin Grond
Robin Lemmens
University Hospitals Leuven [Leuven]
Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven)
Flanders Make [Leuven]
Flanders Make
Leuven Brain Institute [Leuven, Belgium] (LBI)
GrayNumber Analytics [Lomma, Sweden]
Hospices Civils de Lyon (HCL)
Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE)
Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)
Université de Lyon
National Space Science Center [Beijing] (NSSC)
Chinese Academy of Sciences [Beijing] (CAS)
Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE)
University of Glasgow
Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN)
Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
Centre de Recherche en Acquisition et Traitement de l'Image pour la Santé (CREATIS)
Université Jean Monnet [Saint-Étienne] (UJM)-Hospices Civils de Lyon (HCL)-Institut National des Sciences Appliquées de Lyon (INSA Lyon)
Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Girona Biomedical Research Institute [Girona, Spain] (IDIBGI)
Aarhus University Hospital
University of Münster
University of Barcelona
Kreisklinikum Siegen GmbH [Siegen, Germany]
Philipps University of Marburg
Guided Development Heidelberg GmbH [Heidelberg, Germany]
Lifedatascience Consulting [Schriesheim, Germany] (LdSC)
Florey Institute of Neuroscience and Mental Health [Melbourne, Victoria, Australia]
Austin Health
Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon)
Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Westfälische Wilhelms-Universität Münster = University of Münster (WWU)
Philipps Universität Marburg = Philipps University of Marburg
Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
CarMeN, laboratoire
Source :
Stroke, Stroke, American Heart Association, 2021, 52 (7), pp.2338-2346. ⟨10.1161/strokeaha.120.033071⟩, Stroke, 2021, 52 (7), pp.2338-2346. ⟨10.1161/strokeaha.120.033071⟩, Stroke 52(7), 2338-2346 (2021). doi:10.1161/STROKEAHA.120.033071, Scheldeman, L, Wouters, A, Dupont, P, Christensen, S, Boutitie, F, Cheng, B, Ebinger, M, Endres, M, Fiebach, J B, Gerloff, C, Muir, K W, Nighoghossian, N, Pedraza, S, Simonsen, C Z, Ringelstein, E B, Chamorro, A, Grond, M, Laage, R, Schneider, A, Thomalla, G, Thijs, V & Lemmens, R 2021, ' Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion ', Stroke, vol. 52, no. 7, pp. 2338-2346 . https://doi.org/10.1161/STROKEAHA.120.033071
Publication Year :
2021
Publisher :
HAL CCSD, 2021.

Abstract

Background and Purpose: We aimed to investigate fluid-attenuated inversion recovery changes in the penumbra. Methods: We determined core and perfusion lesions in subjects from the WAKE-UP trial (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke) and AXIS 2 trial (Granulocyte Colony-Stimulating Factor in Patients With Acute Ischemic Stroke) with perfusion- and diffusion-weighted imaging at baseline. Only subjects with a mismatch volume >15 mL and ratio >1.2 were included. We created voxel-based relative fluid-attenuated inversion recovery signal intensity (rFLAIR SI) maps at baseline and follow-up. We studied rFLAIR SI in 2 regions of interest: baseline penumbra (baseline perfusion lesion−[core lesion+voxels with apparent diffusion coefficient −6 mm 2 /s]) and noninfarcted penumbra (baseline perfusion lesion−follow-up fluid-attenuated inversion recovery lesion) at 24 hours (WAKE-UP) or 30 days (AXIS 2). We analyzed the association between rFLAIR SI and severity of hypoperfusion, defined as time to maximum of the residue function. Results: In the baseline penumbra, rFLAIR SI was elevated (ratio, 1.04; P =1.7×10 − 13 ; n=126) and correlated with severity of hypoperfusion (Pearson r, 0.03; P − 4 ; n=126). In WAKE-UP, imaging at 24 hours revealed a further increase of rFLAIR SI in the noninfarcted penumbra (ratio, 1.05 at 24 hours versus 1.03 at baseline; P =7.1×10 −3 ; n=43). In AXIS 2, imaging at 30 days identified reversibility of the rFLAIR SI (ratio, 1.02 at 30 days versus 1.04 at baseline; P =1.5×10 −3 ; n=26) since it was no longer different from 1 (ratio, 1.01 at 30 days; P =0.099; n=26). Conclusions: Penumbral rFLAIR SI increases appear early after stroke onset, correlate with severity of hypoperfusion, further increase at 24 hours, and are reversible by 30 days. Registration: URL: https://clinicaltrials.gov ; Unique identifier: NCT01525290. URL: https://clinicaltrials.gov ; Unique identifier: NCT00927836.

Details

Language :
English
ISSN :
00392499 and 15244628
Database :
OpenAIRE
Journal :
Stroke, Stroke, American Heart Association, 2021, 52 (7), pp.2338-2346. ⟨10.1161/strokeaha.120.033071⟩, Stroke, 2021, 52 (7), pp.2338-2346. ⟨10.1161/strokeaha.120.033071⟩, Stroke 52(7), 2338-2346 (2021). doi:10.1161/STROKEAHA.120.033071, Scheldeman, L, Wouters, A, Dupont, P, Christensen, S, Boutitie, F, Cheng, B, Ebinger, M, Endres, M, Fiebach, J B, Gerloff, C, Muir, K W, Nighoghossian, N, Pedraza, S, Simonsen, C Z, Ringelstein, E B, Chamorro, A, Grond, M, Laage, R, Schneider, A, Thomalla, G, Thijs, V & Lemmens, R 2021, ' Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion ', Stroke, vol. 52, no. 7, pp. 2338-2346 . https://doi.org/10.1161/STROKEAHA.120.033071
Accession number :
edsair.doi.dedup.....805a46fd23bab5db5bfd46016bcc7abf
Full Text :
https://doi.org/10.1161/strokeaha.120.033071⟩